Guardian Pharmacy Services, Inc.
GRDN
$20.33
-$0.57-2.73%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.74% | 7.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.74% | 7.69% | |||
| Cost of Revenue | -2.40% | 7.08% | |||
| Gross Profit | -4.11% | 10.23% | |||
| SG&A Expenses | 11.20% | -72.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.43% | -24.26% | |||
| Operating Income | -37.25% | 120.26% | |||
| Income Before Tax | -19.20% | 115.35% | |||
| Income Tax Expenses | -12.49% | 2,388.64% | |||
| Earnings from Continuing Operations | -21.69% | 111.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 71.57% | 101.49% | |||
| Net Income | -20.89% | 110.60% | |||
| EBIT | -37.25% | 120.26% | |||
| EBITDA | -29.53% | 126.45% | |||
| EPS Basic | -20.88% | 109.65% | |||
| Normalized Basic EPS | -34.32% | 117.61% | |||
| EPS Diluted | -21.97% | 109.63% | |||
| Normalized Diluted EPS | -34.51% | 117.42% | |||
| Average Basic Shares Outstanding | 0.00% | 1.47% | |||
| Average Diluted Shares Outstanding | 0.30% | 2.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||